Abstract:Luxun Yang, 1, &ast Haiying Ran, 2, &ast Yaru Yin, 1 Jing Liu, 1 Binghui Lu, 1 Xi Ran, 3 Shenglin Luo, 1 Weidong Wang, 4 Zhangyou Yang, 5 Rong Li 1 1 Institute of Combined Injury, National Key Laboratory of Trauma and Chemical Poisoning, Army Key Laboratory of Nanomedicine, Department of Military Preventive Medicine, Army Medical University, Chongqing, 400038, People's Republic of China; 2 Biomedical Analysis Center, Army Medical University, Chongqing, 400038, People's Republic of China; 3 Department of Medical Laboratory, Xinqiao Hospital, Army Medical University, Chongqing, 400037, People's Republic of China; 4 Department of Radiation Oncology, Sichuan Cancer Hospital, Chengdu, 610041, People's Republic of China; 5 Chongqing Key Laboratory for Pharmaceutical Metabolism Research, Chongqing Pharmacodynamic Evaluation Engineering Technology Research Center, College of Pharmacy, Chongqing Medical University, Chongqing, 400016, People's Republic of China &astThese authors contributed equally to this work Correspondence: Zhangyou Yang, Chongqing Medical University, No. 1, Yixueyuan Road, Chongqing, 400016, People's Republic of China, Email Rong Li, Army Medical University, No. 30, Gaotanyan Street, Chongqing, 400038, People's Republic of China, Tel +86-13883996627, Fax +8623-68753127, Email Purpose: Mitochondrial oxidative stress is an important factor in cell apoptosis. Cerium oxide nanomaterials show great potential for scavenging free radicals and simulating superoxide dismutase (SOD) and catalase (CAT) activities. To solve the problem of poor targeting of cerium oxide nanomaterials, we designed albumin-cerium oxide nanoclusters (TPP-PCNLs) that target the modification of mitochondria with triphenyl phosphate (TPP). TPP-PCNLs are expected to simulate the activity of superoxide dismutase, continuously remove reactive oxygen species, and play a lasting role in radiation protection. Methods: First, cerium dioxide nanoclusters (CNLs), polyethylene glycol cerium dioxide nanoclusters (PCNLs), and TPP-PCNLs were characterized in terms of their morphology and size, ultraviolet spectrum, dispersion stability and cellular uptake, and colocalization Subsequently, the anti-radiation effects of TPP-PCNLs were investigated using in vitro and in vivo experiments including cell viability, apoptosis, comet assays, histopathology, and dose reduction factor (DRF). Results: TPP-PCNLs exhibited good stability and biocompatibility. In vitro experiments indicated that TPP-PCNLs could not only target mitochondria excellently but also regulate reactive oxygen species (ROS)levels in whole cells. More importantly, TPP-PCNLs improved the integrity and functionality of mitochondria in irradiated L-02 cells, thereby indirectly eliminating the continuous damage to nuclear DNA caused by mitochondrial oxidative stress. TPP-PCNLs are mainly targeted to the liver, spleen, and other extramedullary hematopoietic organs with a radiation dose reduction factor of 1.30. In vivo experiments showed that TPP-PCNLs effectively improved the survival rate, weight change, hematopoietic function of irradiated animals. Western blot experiments have confirmed that TPP-PCNLs play a role in radiation protection by regulating the mitochondrial apoptotic pathway. Conclusion: TPP-PCNLs play a radiologically protective role by targeting extramedullary hematopoietic organ-liver cells and mitochondria to continuously clear ROS. Keywords: radioprotective effect, ceria nanoclusters, mitochondria targeting, oxidative stress, superoxide dismutase Ionizing Radiation (IR) produces free radicals and toxic substances when it passes through the cells. Reactive oxygen species (ROS) can attack cellular macromolecules, such as DNA, resulting in DNA breaks, while ROS cause oxidative stress, leading to mitochondrial damage and dysfunction. Mitochondrial oxidative stress is a primary cause of cell death and apoptosis. Anti-radiation drugs are mainly concentrated in sulfur compounds, hormones, plant drugs, cytokines, and other molecules. However, these drugs have certain limitations, such as weak biocompatibility and poor targeting. 1 In addition, traditional anti-radiation drugs to effectively accumulate in the target area of radiation injury, resulting in serious off-target effects and significantly reduced efficacy. Therefore, finding a new radiation protection strategy that combines effective drugs with therapeutic targets is an urgent and difficult problem. It is widely established that mitochondrial ROS plays an important role in DNA repair after radiation damage. Compared with nuclear DNA, -Abstract Truncated-

Mitochondria-Targeted Nitronyl Nitroxide Radical Nanoparticles for Protection against Radiation-Induced Damage with Antioxidant Effects

Radiosensitizer-based Injectable Hydrogel for Enhanced Radio-Chemotherapy of TNBC

A Mitochondria-Targeted Triphenylphosphonium-Conjugated Nitroxide Functions As a Radioprotector/mitigator.

Mitochondrial Targeted Cerium Oxide Nanoclusters for Radiation Protection and Promoting Hematopoiesis

Dopamine-derived Nanoparticles for the Protection of Irradiation-Induced Intestinal Injury by Maintaining Intestinal Homeostasis.

Tumor microenvironment-responsive multifunctional peptide coated ultrasmall gold nanoparticles and their application in cancer radiotherapy.

A Mitochondrially Targeted Nitroxide JP4-039 Protects and Mitigates Against Total Body Irradiation Induced Hematopoietic Syndrome

Mitochondria Targeted Nanoparticles Potentiate Tumor Chemo-Phototherapy by Toxic Oxidative Stress Mediated Oxeiptosis

Nanoparticles Encapsulating Nitrosylated Maytansine to Enhance Radiation Therapy

Anti irradiation nanoparticles shelter immune organ from radio-damage via preventing the IKK/IκB/NF-κB activation

Design and synthesis a mitochondria-targeted dihydronicotinamide as radioprotector.

A Mitochondria-Targeted Nanoradiosensitizer Activating Reactive Oxygen Species Burst for Enhanced Radiation Therapy.

The potential treatment of N-acetylcysteine as an antioxidant in the radiation-induced heart disease

Naturally-Derived PHA-L Protein Nanoparticle As a Radioprotector Through Activation of Toll-Like Receptor 5.

Use Of Titanium-Dioxide Nanoparticles For Increased Cytotoxicity Of Radiation Therapy In Vitro

Two Strategies for the Development of Mitochondrion-Targeted Small Molecule Radiation Damage Mitigators

Protective Effects of 2-Amino-5,6-dihydro-4H-1,3-thiazine and Its Derivative against Radiation-Induced Hematopoietic and Intestinal Injury in Mice

Overcoming Radiation Resistance by Iron-Platinum Metal Alloy Nanoparticles in Human Copper Transport 1-Overexpressing Cancer Cells via Mitochondrial Disturbance

Novel Small Molecule Mitochondrial Targeted Nitroxides Mitigate Total Body Irradiation

One-pot Synthesis of Ultra-Stable Polyvinylpyrrolidone-Modified MnO2 Nanoparticles for Efficient Radiation Protection

The potent radioprotective agents: Novel nitronyl nitroxide radical spin-labeled resveratrol derivatives